Australian professionals’ understandings and experiences of broad consent for the future research use of paediatric genomic data

Broad consent is used to facilitate paediatric genomic research by enabling children’s genomic data to be stored, shared, re-analysed and used in future studies. However, it also raises ethical concerns about whether such consent can be considered to be appropriate and informed, and whether it provides sufficient protection for autonomy. This study examined how Australian clinical, research and data-governance professionals understood and operationalised broad consent for future research use of paediatric genomic data. This qualitative study draws on semi-structured interviews with 20 Australian professionals involved in seeking, explaining, operationalising or governing consent for the research use of paediatric genomic data between February and August 2025. Interviews were analysed thematically. Participants generally described broad consent as workable only when accompanied by clear explanation, proportionate disclosure, voluntary choice, governance oversight and options concerning future contact. Their accounts also identified conditions that could undermine meaningful engagement: diagnostic urgency, emotional pressure, compressed consultations and reliance on professional or institutional trust. Participants varied in how they interpreted the boundaries of broad-consent clauses and when recontact, reaffirmation or re-consent was required. They described the progressive involvement of children and young people as desirable, but not consistently implemented in practice. This study captures professionals’ accounts of how broad consent is understood and operationalised in the future research use of paediatric genomic data. Participants commonly did not regard broad consent as sufficient in itself; they described its appropriate operation as depending on continuing communication, meaningful choices, opportunities to revisit earlier decisions, the progressive involvement of children and young people, and ongoing ethical and institutional oversight. Many of these safeguards were inconsistently understood, unevenly implemented or remained aspirational.

Authors

Institutions

Publication Details

Journal
BMC Medical Ethics
Published
2026-10-15
DOI
https://doi.org/10.1186/s12910-026-01633-x
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Australian professionals’ understandings and experiences of broad consent for the future research use of paediatric genomic data

Louise Anne Keogh, Jane L Nielsen, Bernadette J. Richards, Monica M. Ferrie et al.
BMC Medical Ethics
Ethics in Clinical Research
article

Australian professionals’ understandings and experiences of broad consent for the future research use of paediatric genomic data

Louise Anne Keogh, Jane L Nielsen, Bernadette J. Richards, Monica M. Ferrie, Yingyi Luo
article en

Abstract

Broad consent is used to facilitate paediatric genomic research by enabling children’s genomic data to be stored, shared, re-analysed and used in future studies. However, it also raises ethical concerns about whether such consent can be considered to be appropriate and informed, and whether it provides sufficient protection for autonomy. This study examined how Australian clinical, research and data-governance professionals understood and operationalised broad consent for future research use of paediatric genomic data. This qualitative study draws on semi-structured interviews with 20 Australian professionals involved in seeking, explaining, operationalising or governing consent for the research use of paediatric genomic data between February and August 2025. Interviews were analysed thematically. Participants generally described broad consent as workable only when accompanied by clear explanation, proportionate disclosure, voluntary choice, governance oversight and options concerning future contact. Their accounts also identified conditions that could undermine meaningful engagement: diagnostic urgency, emotional pressure, compressed consultations and reliance on professional or institutional trust. Participants varied in how they interpreted the boundaries of broad-consent clauses and when recontact, reaffirmation or re-consent was required. They described the progressive involvement of children and young people as desirable, but not consistently implemented in practice. This study captures professionals’ accounts of how broad consent is understood and operationalised in the future research use of paediatric genomic data. Participants commonly did not regard broad consent as sufficient in itself; they described its appropriate operation as depending on continuing communication, meaningful choices, opportunities to revisit earlier decisions, the progressive involvement of children and young people, and ongoing ethical and institutional oversight. Many of these safeguards were inconsistently understood, unevenly implemented or remained aspirational.

BMC Medical Ethics
University of Tasmania (AU), The University of Queensland (AU), The University of Melbourne (AU), Breast Cancer Network Australia (AU)
Medical Research Future Fund
Good health and well-being
Openalex Percentile: Top 10%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.